When should upfront molecular sequencing be performed in a pediatric or AYA patient with sarcoma?  

There is no standard to be able to provide a clear answer and I believe that the decision to perform sequencing would need to be determined on an individualized basis.  I would consider doing so in cases of advanced disease when standard therapies are less likely to provide benefit and there i...